Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1592, 2007-01, pp. : 14-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Does `NICE blight' exist, and if so, why?
By Haycox Alan
PharmacoEconomics, Vol. 26, Iss. 12, 2008-01 ,pp. :
Access to resources
Recommend
The controversy of a wider statin utilization: why?
By Mansi Ishak
Expert Opinion on Drug Safety, Vol. 12, Iss. 3, 2013-05 ,pp. :
Why is healthcare spending so high in the US?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 654, 2012-01 ,pp. :
Are medical error deaths overstated in IOM report?
Inpharma, Vol. 1, Iss. 1246, 2000-01 ,pp. :
Bivalirudin preferable in coronary angioplasty?
Inpharma, Vol. 1, Iss. 1324, 2002-01 ,pp. :